#BEGIN_DRUGCARD DB08120

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
43711

# Chemical_Formula:
C8H17NOS2

# Chemical_IUPAC_Name:
(6R)-6,8-disulfanyloctanamide

# Chemical_Structure:
Not Available

# Creation_Date:
2010-09-15 15:28:44 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
6,8-DIMERCAPTO-OCTANOIC ACID AMIDE

# HET_ID:
LPM

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C8H17NOS2/c9-8(10)4-2-1-3-7(12)5-6-11/h7,11-12H,1-6H2,(H2,9,10)/t7-/m1/s1

# InChI_Key:
InChIKey=VLYUGYAKYZETRF-SSDOTTSWSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
8126

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
207.357

# Molecular_Weight_Mono:
207.075155551

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.61

# Predicted_LogS:
-3.4

# Predicted_Water_Solubility:
7.53e-02 g/l

# Primary_Accession_No:
DB08120

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
445160

# PubChem_Substance_ID:
99444591

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[H][C@](S)(CCS)CCCCC(N)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:26:28 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X12455

# Drug_Target_1_GenBank_ID_Protein:
580740

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
>1917 bp
GTGAGCGAAATCATCCGCGTACCCGATATCGGCGGCGATGGGGAAGTCATCGAATTGCTG
GTCAAGACCGGCGACCTCATCGAGGTCGAGCAGGGGCTGGTGGTGCTGGAGTCCGCCAAG
GCGAGCATGGAAGTTCCCAGTCCCAAGGCCGGAGTGGTCAAGAGCGTGAGCGTCAAGCTG
GGCGACAAGCTCAAGGAAGGCGACGCGATCATCGAGCTGGAACCTGCCGCCGGTGCCGCG
GCGGCACCTGCCGAAGCGGCGGCCGTGCCCGCCGCGCCGACCCAGGCCGTCGACGAGGCC
GAGGCGCCCTCTCCCGGCGCCTCCGCCACGCCCGCGCCGGCCGCCGCCAGCCAGGAGGTC
CGGGTTCCCGACATCGGCTCGGCCGGCAAGGCACGGGTCATCGAGGTGCTGGTCAAGGCC
GGCGACCAGGTCCAGGCCGAGCAGTCGCTGATCGTGCTGGAGTCCGACAAGGCCAGCATG
GAGATCCCCTCCCCGGCTTCCGGAGTGGTGGAAAGCGTCGCCATCCAGTTGAACGCCGAG
GTCGGCACCGGCGACCTGATCCTCACCCTGCGCACCACCGGCGCCCAGGCCCAGCCTACG
GCGCCCGCCGCGGCCGCGGCCGCGAGCCCGGCACCCGCTCCGCTGGCTCCGGCCGCCGCC
GGTCCCCAGGAAGTCAAGGTCCCGGACATCGGCTCGGCCGGCAAGGCACGGGTCATCGAG
GTGCTGGTCAAGGCCGGCGACCAGGTCCAGGCCGAACAGTCGCTGATCGTGCTGGAATCC
GACAAGGCCAGCATGGAGATCCCCTCCCCGGCCGCCGGGGTGGTGGAAAGCGTCGCCGTC
CAGTTGAACGCCGAGGTCGGCACCGGCGATCAGATCCTCACCCTGCGCGTCGCCGGCGCC
GCGCCGAGCGGCCCCCGCGCCCGCGGCAGCCCCGGCCAAGCCGCCGCCGCTGCGGCCGCT
GCCCCGGCTCCGGCCCCGGTCGGCGCACCGAGCCGCAACGGCGCCAAGGTGCATGCCGGC
CCCGCCGTGCGCCAACTGGCCCGCGAGTTCGGCGTCGAACTGGCGGCGATCAACAGCACC
GGTCCGCGCGGGCGCATCCTCAAGGAGGACGTGCAGGCCTACGTCAAGGCGATGATGCAG
AAGGCCAAGGAGGCGCCGGCCGCCGGCGCGGCCAGCGGCGCCGGCATCCCGCCGATTCCG
CCGGTCGACTTCGCCAAGTACGGCGAAATCGAAGAAGTGCCGATGACTCGCCTGATGCAG
ATCGGCGCGACCAACCTGCACCGCAGTTGGCTGAACGTGCCGCACGTGACCCAGTTCGAG
TCGGCCGATATCACCGAGCTGGAAGCCTTCCGCGTCGCGCAGAAGGCCGTCGCCGAGAAG
GCCGGGGTCAAGCTGACCGTGCTGCCGCTGCTGCTCAAGGCCTGCGCCTACCTGCTCAAG
GAGCTGCCGGACTTCAACAGCTCCCTGGCACCCAGCGGCCAGGCGCTGATCCGCAAGAAG
TACGTGCACATCGGCTTCGCCGTGGACACCCCGGACGGCCTGCTGGTGCCGGTAATCCGC
AACGTCGACCAGAAGAGCCTGCTGCAACTGGCCGCCGAGGCCGCCGAACTGGCGGAGAAG
GCGCGCAGCAAGAAGCTCGGCGCCGACGCCATGCAGGGTGCCTGCTTCACCATCTCCAGC
CTCGGCCACATCGGCGGCACGGCCTTCACGCCGATCGTCAACGCCCCGGAAGTGGCGATC
CTCGGCGTGTCCAAGGCCAGCATGCAGCCGGTATGGGACGGCAAGGCCTTCCAGCCGCGC
CTGATGCTGCCGCTGTCGCTGTCCTACGATCACCGGGTGATCAACGGCGCCGCCGCGGCG
CGCTTCACCAAGCGTCTCGGCGACCTGCTGGCGGATATCCGCGCCATCCTGCTGTGA

# Drug_Target_1_General_Function:
Energy production and conversion

# Drug_Target_1_General_References:
1549782	Mattevi A, Obmolova G, Schulze E, Kalk KH, Westphal AH, de Kok A, Hol WG: Atomic structure of the cubic core of the pyruvate dehydrogenase multienzyme complex. Science. 1992 Mar 20;255(5051):1544-50.
3191993	Hanemaaijer R, Vervoort J, Westphal AH, de Kok A, Veeger C: Mobile sequences in the pyruvate dehydrogenase complex, the E2 component, the catalytic domain and the 2-oxoglutarate dehydrogenase complex of Azotobacter vinelandii, as detected by 600 MHz 1H-NMR spectroscopy. FEBS Lett. 1988 Nov 21;240(1-2):205-10.
3292237	Hanemaaijer R, Janssen A, de Kok A, Veeger C: The dihydrolipoyltransacetylase component of the pyruvate dehydrogenase complex from Azotobacter vinelandii. Molecular cloning and sequence analysis. Eur J Biochem. 1988 Jul 1;174(4):593-9.
3691494	Hanemaaijer R, de Kok A, Jolles J, Veeger C: The domain structure of the dihydrolipoyl transacetylase component of the pyruvate dehydrogenase complex from Azotobacter vinelandii. Eur J Biochem. 1987 Dec 1;169(2):245-52.
8068086	Berg A, de Kok A, Vervoort J: Sequential 1H and 15N nuclear magnetic resonance assignments and secondary structure of the N-terminal lipoyl domain of the dihydrolipoyl transacetylase component of the pyruvate dehydrogenase complex from Azotobacter vinelandii. Eur J Biochem. 1994 Apr 1;221(1):87-100.
9119000	Berg A, Vervoort J, de Kok A: Three-dimensional structure in solution of the N-terminal lipoyl domain of the pyruvate dehydrogenase complex from Azotobacter vinelandii. Eur J Biochem. 1997 Mar 1;244(2):352-60.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2377

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
65045

# Drug_Target_1_Name:
Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex

# Drug_Target_1_Number_of_Residues:
638

# Drug_Target_1_PDB_ID:
1DPD

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00198	2-oxoacid_dh
PF00364	Biotin_lipoyl
PF02817	E3_binding

# Drug_Target_1_Protein_Sequence:
>Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MSEIIRVPDIGGDGEVIELLVKTGDLIEVEQGLVVLESAKASMEVPSPKAGVVKSVSVKL
GDKLKEGDAIIELEPAAGAAAAPAEAAAVPAAPTQAVDEAEAPSPGASATPAPAAASQEV
RVPDIGSAGKARVIEVLVKAGDQVQAEQSLIVLESDKASMEIPSPASGVVESVAIQLNAE
VGTGDLILTLRTTGAQAQPTAPAAAAAASPAPAPLAPAAAGPQEVKVPDIGSAGKARVIE
VLVKAGDQVQAEQSLIVLESDKASMEIPSPAAGVVESVAVQLNAEVGTGDQILTLRVAGA
APSGPRARGSPGQAAAAPGAAPAPAPVGAPSRNGAKVHAGPAVRQLAREFGVELAAINST
GPRGRILKEDVQAYVKAMMQKAKEAPAAGAASGAGIPPIPPVDFAKYGEIEEVPMTRLMQ
IGATNLHRSWLNVPHVTQFESADITELEAFRVAQKAVAEKAGVKLTVLPLLLKACAYLLK
ELPDFNSSLAPSGQALIRKKYVHIGFAVDTPDGLLVPVIRNVDQKSLLQLAAEAAELAEK
ARSKKLGADAMQGACFTISSLGHIGGTAFTPIVNAPEVAILGVSKASMQPVWDGKAFQPR
LMLPLSLSYDHRVINGAAAARFTKRLGDLLADIRAILL

# Drug_Target_1_Reaction:
acetyl-CoA + enzyme N6-(dihydrolipoyl)lysine = CoA + enzyme N6-(S-acetyldihydrolipoyl)lysine

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2). It contains multiple copies of three enzymatic components:pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase (E3)

# Drug_Target_1_SwissProt_ID:
P10802

# Drug_Target_1_SwissProt_Name:
ODP2_AZOVI

# Drug_Target_1_Synonyms:
Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex
E2
EC 2.3.1.12

# Drug_Target_1_Theoretical_pI:
5.12

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB08120
